After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine ...
Chai Discovery, an artificial intelligence drug-discovery company backed by Sam Altman’s OpenAI, has secured $130 million ...
The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...
In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they’re working. Inside a lab at the Massachusetts Institute of Technology late last ...
Medra, a developer of AI-powered lab robots and scientists to advance drug discovery, raises $52M - SiliconANGLE ...
Stockhead on MSN
Biocurious: AI becomes the hidden helping hand in clinical trial design and analysis
Drug developers increasingly are harnessing AI to optimise clinical trial patient selection and to interpret results to ...
This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
Duke researchers have developed a new AI-powered approach to nanoparticle drug delivery design, which performed well in lab tests with cancer drugs Drugs that fight diseases work best when they reach ...
An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback